Chronic care model in the diabetes pay-for-performance program in Taiwan: Benefits, challenges and future directions
- PMID: 33995846
- PMCID: PMC8107979
- DOI: 10.4239/wjd.v12.i5.578
Chronic care model in the diabetes pay-for-performance program in Taiwan: Benefits, challenges and future directions
Abstract
In this review, we discuss the chronic care model (CCM) in relation to the diabetes pay-for-performance (P4P) program in Taiwan. We first introduce the 6 components of the CCM and provide a detailed description of each of the activities in the P4P program implemented in Taiwan, mapping them onto the 6 components of the CCM. For each CCM component, the following three topics are described: the definition of the CCM component, the general activities implemented related to this component, and practical and empirical practices based on hospital or local government cases. We then conclude by describing the possible successful features of this P4P program and its challenges and future directions. We conclude that the successful characteristics of this P4P program in Taiwan include its focus on extrinsic and intrinsic incentives (i.e., shared care network), physician-led P4P and the implementation of activities based on the CCM components. However, due to the low rate of P4P program coverage, approximately 50% of patients with diabetes cannot enjoy the benefits of CCM-related activities or receive necessary examinations. In addition, most of these CCM-related activities are not allotted an adequate amount of incentives, and these activities are mainly implemented in hospitals, which compared with primary care providers, are unable to execute these activities flexibly. All of these issues, as well as insufficient implementation of the e-CCM model, could hinder the advanced improvement of diabetes care in Taiwan.
Keywords: Chronic care model; Diabetes; Diabetes care; Pay-for-performance; Shared care.
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: We have no financial relationships to disclose.
Figures
Similar articles
-
A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan.Int J Qual Health Care. 2017 Aug 1;29(4):512-520. doi: 10.1093/intqhc/mzx057. Int J Qual Health Care. 2017. PMID: 28531317
-
Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study.Medicine (Baltimore). 2016 Jul;95(27):e4197. doi: 10.1097/MD.0000000000004197. Medicine (Baltimore). 2016. PMID: 27399144 Free PMC article.
-
The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study.Prev Med. 2016 Apr;85:53-59. doi: 10.1016/j.ypmed.2015.12.013. Epub 2015 Dec 29. Prev Med. 2016. PMID: 26740347
-
Identifying organisational principles and management practices important to the quality of health care services for chronic conditions.Dan Med J. 2012 Feb;59(2):B4387. Dan Med J. 2012. PMID: 22293057 Review.
-
The influence of welfare systems on pay-for-performance programs for general practitioners: A critical review.Soc Sci Med. 2017 Apr;178:157-166. doi: 10.1016/j.socscimed.2017.02.019. Epub 2017 Feb 16. Soc Sci Med. 2017. PMID: 28226301 Review.
Cited by
-
Assessing Taiwan's pay-for-performance program for diabetes care: a cost-benefit net value approach.Eur J Health Econ. 2023 Jul;24(5):717-733. doi: 10.1007/s10198-022-01504-3. Epub 2022 Aug 22. Eur J Health Econ. 2023. PMID: 35995886
-
Validation of Stroke Risk Factors in Patients with Acute Ischemic Stroke, Transient Ischemic Attack, or Intracerebral Hemorrhage on Taiwan's National Health Insurance Claims Data.Clin Epidemiol. 2022 Mar 17;14:327-335. doi: 10.2147/CLEP.S353435. eCollection 2022. Clin Epidemiol. 2022. PMID: 35330593 Free PMC article.
-
The Feasibility and Impact of Implementing Interventions to Reduce Short-Acting β2-Agonist Over-Reliance in Asthma: An Expert Opinion.Adv Ther. 2025 Aug 6. doi: 10.1007/s12325-025-03293-6. Online ahead of print. Adv Ther. 2025. PMID: 40768188 Review.
-
Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis.Cost Eff Resour Alloc. 2023 Jul 6;21(1):41. doi: 10.1186/s12962-023-00450-y. Cost Eff Resour Alloc. 2023. PMID: 37415154 Free PMC article.
-
Kidney Disease: Improving Global Outcomes Summit Recommendations on Implementation of Diabetes Management in CKD: From Primary to Data-Driven Collaborative Care.Kidney Int Rep. 2025 Jun 18;10(8):2551-2565. doi: 10.1016/j.ekir.2025.06.010. eCollection 2025 Aug. Kidney Int Rep. 2025. PMID: 40814615 Free PMC article.
References
-
- Iezzi E, Lippi Bruni M, Ugolini C. The role of GP's compensation schemes in diabetes care: evidence from panel data. J Health Econ. 2014;34:104–120. - PubMed
-
- Ryan AM, Doran T. The effect of improving processes of care on patient outcomes: evidence from the United Kingdom's quality and outcomes framework. Med Care. 2012;50:191–199. - PubMed
-
- Tompkins CP, Higgins AR, Ritter GA. Measuring outcomes and efficiency in medicare value-based purchasing. Health Aff (Millwood) 2009;28:w251–w261. - PubMed
-
- Girault A, Bellanger M, Lalloué B, Loirat P, Moisdon JC, Minvielle E. Implementing hospital pay-for-performance: Lessons learned from the French pilot program. Health Policy. 2017;121:407–417. - PubMed
-
- Yang JH, Kim SM, Han SJ, Knaak M, Yang GH, Lee KD, Yoo YH, Ha G, Kim EJ, Yoo MS. The impact of Value Incentive Program (VIP) on the quality of hospital care for acute stroke in Korea. Int J Qual Health Care. 2016;28:580–585. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources